acetylglucosamine has been researched along with Infarction, Middle Cerebral Artery in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, M; Li, Y; Liu, S; Paschen, W; Sheng, H; Warner, DS; Yang, W; Yu, S; Yu, Z | 1 |
| Abe, K; Feng, T; Fukui, Y; Hasumi, K; Hishikawa, N; Huang, Y; Liu, X; Morihara, R; Nakano, Y; Ohta, Y; Sato, K; Shang, J; Shi, X; Suzuki, E; Takemoto, M; Yamashita, T | 1 |
| Cai, E; Ding, F; Gu, H; Xu, H; Yang, Y; Yu, S | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Kono, S; Kurata, T; Omote, Y; Sato, K; Yamashita, T | 1 |
| Ding, F; Liu, X; Shen, Y; Xu, H; Yang, Y; Yu, S | 1 |
5 other study(ies) available for acetylglucosamine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
XBP1 (X-Box-Binding Protein-1)-Dependent O-GlcNAcylation Is Neuroprotective in Ischemic Stroke in Young Mice and Its Impairment in Aged Mice Is Rescued by Thiamet-G.
Topics: Acetylglucosamine; Age Factors; Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotection; Protein Folding; Protein Serine-Threonine Kinases; Pyrans; Stroke; Thiazoles; Unfolded Protein Response; X-Box Binding Protein 1 | 2017 |
Neuroprotective effects of SMTP-44D in mice stroke model in relation to neurovascular unit and trophic coupling.
Topics: Acetylglucosamine; Animals; Apoptosis; Blood Vessels; Brain Infarction; Brain-Derived Neurotrophic Factor; Calcium-Binding Proteins; Caspase 3; DNA-Binding Proteins; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred ICR; Microfilament Proteins; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Oxidative Stress; Phenols; Pyroptosis; Stachybotrys; Stroke; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha | 2018 |
2-(4-Methoxyphenyl)Ethyl-2-Acetamido-2-Deoxy-β-D-Pyranoside Exerts a Neuroprotective Effect through Regulation of Energy Homeostasis and O-GlcNAcylation.
Topics: Acetylglucosamine; Animals; Cell Hypoxia; Cells, Cultured; Energy Metabolism; Glucose; Hippocampus; Homeostasis; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Oxygen; Rats; Rats, Sprague-Dawley | 2019 |
Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
Topics: Acetylglucosamine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Carrier Proteins; Cerebral Cortex; Collagen Type IV; Disease Models, Animal; Encephalitis; Glial Fibrillary Acidic Protein; Hypertension; Infarction, Middle Cerebral Artery; Inflammasomes; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Inbred SHR; Telmisartan; Time Factors | 2015 |
Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
Topics: Acetylglucosamine; Animals; Brain; Cerebral Hemorrhage; Combined Modality Therapy; Disease Models, Animal; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats, Sprague-Dawley; Recovery of Function; Stroke; Tissue Plasminogen Activator | 2016 |